Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.01 CAD | -.--% | +100.00% | +100.00% |
Jan. 26 | Optimind Pharma Reaches Agreement On Debenture Conversion | MT |
Jan. 10 | Optimind Pharma Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended November 30, 2023 | CI |
Sales 2022 | 99.69K 73.1K | Sales 2023 | 170K 125K | Capitalization | 3.91M 2.87M |
---|---|---|---|---|---|
Net income 2022 | - 0 | Net income 2023 | -3M -2.2M | EV / Sales 2022 * | - |
Net cash position 2022 | 1.22M 894K | Net Debt 2023 | 61.19K 44.87K | EV / Sales 2023 | 23.4 x |
P/E ratio 2022 * |
-
| P/E ratio 2023 |
-1.07
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 92.31% |
1 week | +100.00% | ||
1 month | +100.00% | ||
3 months | +100.00% | ||
Current year | +100.00% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 0.01 | -.--% | 51,000 |
24-05-29 | 0.01 | +100.00% | 235,958 |
24-05-27 | 0.005 | -.--% | 242,590 |
24-05-24 | 0.005 | -.--% | 256,500 |
Delayed Quote Canadian Securities Exchange, May 31, 2024 at 01:34 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+100.00% | 719K | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- OMND Stock